Costs of Parkinson’s Disease in a Privately Insured Population

BACKGROUND: This is the first analysis to estimate the costs of commercially insured patients with Parkinson’s disease (PD) in the USA. Prior analyses of PD have not examined costs in patients aged under 65 years, a majority of whom are in the workforce. OBJECTIVE: Our objective was to estimate dire...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Scott J., Kaltenboeck, Anna, Diener, Melissa, Birnbaum, Howard G., Grubb, ElizaBeth, Castelli-Haley, Jane, Siderowf, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757266/
https://www.ncbi.nlm.nih.gov/pubmed/23907717
http://dx.doi.org/10.1007/s40273-013-0075-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757266/
https://www.ncbi.nlm.nih.gov/pubmed/23907717
http://dx.doi.org/10.1007/s40273-013-0075-0

Ejemplares similares